Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 7 Breast Neoplasms 6 Neoplasm Metastasis 1 BRCA-Mutated Breast Carcinoma 1

Interventions

Paclitaxel 50 Capecitabine 50 Trastuzumab 38 Fulvestrant 31 pembrolizumab 27 Cyclophosphamide 27 Carboplatin 27 Gemcitabine 23 Letrozole 21 palbociclib 19 Docetaxel 19 Lapatinib 18 Bevacizumab 18 exemestane 17 eribulin 15 Everolimus 14 abemaciclib 13 Vinorelbine 13 Nivolumab 13 Magnetic Resonance Spectroscopy 12 Cisplatin 12 Anastrozole 12 trastuzumab deruxtecan 11 Zoledronic Acid 11 Doxorubicin 11 Albumin-Bound Paclitaxel 11 olaparib 10 Tamoxifen 10 Specimen Handling 10 Radiotherapy 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × famitinib × Breast × Clear all

NCT04355858 2022-07-26

MULAN

Fudan University

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡